These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 38678084)

  • 1. Long COVID: plasma levels of neurofilament light chain in mild COVID-19 patients with neurocognitive symptoms.
    Gutman EG; Salvio AL; Fernandes RA; Duarte LA; Raposo-Vedovi JV; Alcaraz HF; Teixeira MA; Passos GF; de Medeiros KQM; Hammerle MB; Pires KL; Vasconcelos CCF; Leon LAA; Figueiredo CP; Alves-Leon SV
    Mol Psychiatry; 2024 Oct; 29(10):3106-3116. PubMed ID: 38678084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection.
    Hanson BA; Visvabharathy L; Ali ST; Kang AK; Patel TR; Clark JR; Lim PH; Orban ZS; Hwang SS; Mattoon D; Batra A; Liotta EM; Koralnik IJ
    Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35256481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
    Darmanthé N; Tabatabaei-Jafari H; Cherbuin N;
    J Alzheimers Dis; 2021; 82(3):951-964. PubMed ID: 34120902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.
    Gatson JW; Barillas J; Hynan LS; Diaz-Arrastia R; Wolf SE; Minei JP
    J Neurosurg; 2014 Nov; 121(5):1232-8. PubMed ID: 25192482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of blood pressure variability and plasma neurofilament light in the mechanism of comorbidity between Alzheimer's disease and cerebral small vessel disease.
    Li Q; Su S; Feng Y; Jia M; Zhan J; Liao Z; Li J; Li X;
    Alzheimers Dement; 2024 Jul; 20(7):4891-4902. PubMed ID: 38895921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up.
    Kanberg N; Simrén J; Edén A; Andersson LM; Nilsson S; Ashton NJ; Sundvall PD; Nellgård B; Blennow K; Zetterberg H; Gisslén M
    EBioMedicine; 2021 Aug; 70():103512. PubMed ID: 34333238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Levels of NfL, GFAP, TAU, and UCH-L1 as Potential Predictor Biomarkers of Severity and Lethality in Acute COVID-19.
    Salvio AL; Fernandes RA; Ferreira HFA; Duarte LA; Gutman EG; Raposo-Vedovi JV; Filho CHFR; da Costa Nunes Pimentel Coelho WL; Passos GF; Andraus MEC; da Costa Gonçalves JP; Cavalcanti MG; Amaro MP; Kader R; de Andrade Medronho R; Figueiredo CP; Amado-Leon LA; Alves-Leon SV
    Mol Neurobiol; 2024 Jun; 61(6):3545-3558. PubMed ID: 37996731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of Plasma Neurofilament Light in the 1Florida Alzheimer's Disease Research Center (ADRC).
    Barker W; Quinonez C; Greig MT; Behar R; Chirinos C; Rodriguez RA; Rosselli M; Rodriguez MJ; Cid RC; Rundek T; McFarland K; Hanson K; Smith G; DeKosky S; Vaillancourt D; Adjouadi M; Marsiske M; Ertekin-Taner N; Golde T; Loewenstein DA; Duara R
    J Alzheimers Dis; 2021; 79(1):59-70. PubMed ID: 33216030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection.
    Hanson BA; Visvabharathy L; Orban ZS; Jimenez M; Batra A; Liotta EM; DeLisle RK; Klausner JD; Cohen P; Padhye AS; Tachas G; Koralnik IJ
    Brain Behav Immun; 2023 Nov; 114():462-474. PubMed ID: 37704012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma neurofilament light chain levels in chemotherapy-induced peripheral neurotoxicity according to type of anticancer drug.
    Velasco R; Marco C; Domingo-Domenech E; Stradella A; Santos C; Laquente B; Ferrer G; Argyriou AA; Bruna J
    Eur J Neurol; 2024 Sep; 31(9):e16369. PubMed ID: 38952074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Neurofilament Light Chain Is Associated with Poor Functional Outcome and Mortality Rate After Spontaneous Subarachnoid Hemorrhage.
    Hviid CVB; Lauridsen SV; Gyldenholm T; Sunde N; Parkner T; Hvas AM
    Transl Stroke Res; 2020 Aug; 11(4):671-677. PubMed ID: 31808039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma neurofilament light chain is associated with mortality after spontaneous intracerebral hemorrhage.
    Hviid CVB; Gyldenholm T; Lauridsen SV; Hjort N; Hvas AM; Parkner T
    Clin Chem Lab Med; 2020 Jan; 58(2):261-267. PubMed ID: 31494627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long COVID or Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and the Urgent Need to Identify Diagnostic Biomarkers and Risk Factors.
    Parums DV
    Med Sci Monit; 2024 Sep; 30():e946512. PubMed ID: 39289865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes.
    Lennol MP; Ashton NJ; Moreno-Pérez O; García-Ayllón MS; Ramos-Rincon JM; Andrés M; León-Ramírez JM; Boix V; Gil J; Blennow K; Merino E; Zetterberg H; Sáez-Valero J
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High efavirenz levels but not neurofilament light plasma levels are associated with poor neurocognitive functioning in asymptomatic HIV patients.
    Hakkers CS; Hermans AM; van Maarseveen EM; Teunissen CE; Verberk IMW; Arends JE; Hoepelman AIM
    J Neurovirol; 2020 Aug; 26(4):572-580. PubMed ID: 32524424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19.
    Bark L; Larsson IM; Wallin E; Simrén J; Zetterberg H; Lipcsey M; Frithiof R; Rostami E; Hultström M
    Sci Rep; 2023 Aug; 13(1):13144. PubMed ID: 37573366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological involvement among non-hospitalized adolescents and young adults 6 months after acute COVID-19.
    Havdal LB; Selvakumar J; Lund Berven L; Stiansen-Sonerud T; Zetterberg H; Blennow K; Holmøy T; Wyller VBB
    Front Neurol; 2024; 15():1345787. PubMed ID: 38385031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Markers Predict Blood Neurofilament Light Chain Levels in Acute COVID-19 Patients.
    De Lorenzo R; Loré NI; Finardi A; Mandelli A; Calesella F; Palladini M; Cirillo DM; Tresoldi C; Ciceri F; Rovere-Querini P; Manfredi AA; Mazza MG; Benedetti F; Furlan R
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis.
    Manouchehrinia A; Stridh P; Khademi M; Leppert D; Barro C; Michalak Z; Benkert P; Lycke J; Alfredsson L; Kappos L; Piehl F; Olsson T; Kuhle J; Kockum I
    Neurology; 2020 Jun; 94(23):e2457-e2467. PubMed ID: 32434867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic performance of plasma neurofilament light chain in multiple system atrophy: a cross-sectional and longitudinal study.
    Peng L; Wan L; Liu M; Long Z; Chen D; Yuan X; Tang Z; Fu Y; Zhu S; Lei L; Wang C; Peng H; Shi Y; He L; Yuan H; Wan N; Hou X; Xia K; Li J; Chen C; Qiu R; Tang B; Chen Z; Jiang H
    J Neurol; 2023 Sep; 270(9):4248-4261. PubMed ID: 37184660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.